Ellen S. Vitetta - Concepedia

Author

Ellen S. Vitetta

The University of Texas Southwestern Medical Center

Also Known As

E S Vitetta, ELLEN S. VITETTA, Ellen S Vitetta, Ellen S. Vitetta, Ellen S.Vitetta, Ellen Vitetta, Ellen. S. Vitetta, Ellen S. Vitetta, Ellen S. Vitetta

307

Publications

14.6K

Citations

H-Index

163

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Southwestern Medical Center New York University

About

Ellen S. Vitetta is an author at The University of Texas Southwestern Medical Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	114	7.3K
2	Allergy	26	38	2.2K
3	Natural Sciences	11	11	292
4	Health Sciences	3	3	108
5	Engineering	2	2	96

Ellen S. Vitetta

172

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells Tracy L. Stevens, A Bossie, Virginia M. Sanders, Nature Autoimmune DiseaseAntibody Isotype SecretionAdaptive Immune SystemT-regulatory CellImmunology	1988	938
<i>HER-2</i> gene amplification can be acquired as breast cancer progresses Songdong Meng, Debasish Tripathy, Sanjay Shete, Proceedings of the National Academy of Sciences	2004	506
Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes Pavitra Chakravarty, Radu Marcheş, Neil S. Zimmerman, Proceedings of the National Academy of Sciences	2008	379
CELL SURFACE IMMUNOGLOBULIN Ellen S. Vitetta, Sonia Baur, Jonathan W. Uhr The Journal of Experimental Medicine Immunocytochemical TechniqueLaboratory ImmunologyCell Surface ImmunoglobulinImmunologyImmunophenotyping	1971	377
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Francis Burrows, Elaine J. Derbyshire, Pier Luigi Tazzari, PubMed Endothelial CellsImmunologyEndoglin ExpressionHuman Solid TumorsTumor Biology	1995	336
Immunoglobulin-Receptors Revisited Ellen S. Vitetta, Jonathan W. Uhr Science	1975	297
Immunotoxins: A New Approach to Cancer Therapy Ellen S. Vitetta, Keith A. Krolick, Muneo Miyama-Inaba, Science Cancer TherapySuch ImmunotoxinsCancer ImmunosurveillanceImmunotoxicologyMedicine	1983	276
Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study Isabelle André‐Schmutz, Françoise Le Deist, Salima Hacein‐Bey‐Abina, The Lancet Phase 1/2TransplantationMarrow TransplantationStem Cell TransplantationImmunology	2002	217
Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome Roxana Baluna, Josep Rizo, Brian Gordon, Proceedings of the National Academy of Sciences	1999	203
Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin Maria-Ana Ghetie, Helen Bright, Ellen S. Vitetta Blood	2001	190

Page 1